Portfolio and APVC news
Watch the APVC team speak at the 2020 Medtech Strategists Virtual Summit about bioelectronic medicine, investments, trends, and their commitment to diversity & inclusion.
Listen to APVC partner Juan-Pablo Mas speak with Tom Salemi of the Device Talks Weekly podcost about the potential of ultrasound in bioelectronic medicine
SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectronic Platform
We are proud to announce that APVC Executive-in-Residence, Rami Elghandour was recently appointed Chairman of the Board and CEO of Arcellx. Rami will lead Arcellx as it advances its transformative cancer and autoimmune therapies.
CVRx Barostim Therapy Receives CMS Approval for Transitional Pass-Through Payment Status
Cala Health Receives FDA Breakthrough Designation for Cala Trio Therapy to Treat Action Tremors in Parkinson's Disease
Axon Therapies Announces Positive Results From First In-Human Clinical Study in Late Breaking Clinical Trial Session at 2020 Virtual HFSA Conference
SetPoint Medical Receives FDA Breakthrough Designation for Its Novel Bioelectronic Platform
CVRx's Barostim Neo Receives CMS NTAP